AD04 Advancing to Phase III Amid Promising Results in Alcohol Use Disorder

Posted on by admin

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol use disorder.

Leave a Reply

Your email address will not be published. Required fields are marked *